Cargando…
A Concise Review of the Recent Structural Explorations of Chromones as MAO-B Inhibitors: Update from 2017 to 2023
Monoamine oxidases (MAOs) are a family of flavin adenine dinucleotide-dependent enzymes that catalyze the oxidative deamination of a wide range of endogenous and exogenous amines. Multiple neurological conditions, including Parkinson’s disease (PD) and Alzheimer’s disease (AD), are closely correlate...
Autores principales: | Ipe, Reshma Susan, Kumar, Sunil, Benny, Feba, Jayan, Jayalakshmi, Manoharan, Amritha, Sudevan, Sachitra Thazhathuveedu, George, Ginson, Gahtori, Prashant, Kim, Hoon, Mathew, Bijo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534638/ https://www.ncbi.nlm.nih.gov/pubmed/37765118 http://dx.doi.org/10.3390/ph16091310 |
Ejemplares similares
-
“Click Chemistry”: An Emerging Tool
for Developing a New Class of Structural Motifs against Various Neurodegenerative
Disorders
por: Manoharan, Amritha, et al.
Publicado: (2023) -
Assembling a Cinnamyl Pharmacophore in the C3-Position of Substituted Isatins via Microwave-Assisted Synthesis: Development of a New Class of Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson’s Disease
por: Manoharan, Amritha, et al.
Publicado: (2023) -
Piperidine: A Versatile Heterocyclic Ring for Developing
Monoamine Oxidase Inhibitors
por: Jayan, Jayalakshmi, et al.
Publicado: (2023) -
Navigating into the Chemical Space of Monoamine Oxidase
Inhibitors by Artificial Intelligence and Cheminformatics Approach
por: Kumar, Sunil, et al.
Publicado: (2021) -
Current and Future Nano-Carrier-Based Approaches in the Treatment of Alzheimer’s Disease
por: Kumar, Astik, et al.
Publicado: (2023)